Biotech · Private company
bioRASI, LLC
Track this companyFree. Adds bioRASI, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials131 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- Reference: Metronidazole Gel 1%Phase 3 · Papulopustular RosaceaClinicalTrials.gov · fetched Nov 12, 2026
- Test: Metronidazole Gel 1%Phase 3 · Papulopustular RosaceaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials13
- Study in Subjects With Mild-to-Moderate Alzheimer's DementiaPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jul 5, 2023ClinicalTrials.gov NCT05834296 · fetched Nov 12, 2026
- Lomecel-B Effects on Alzheimer's DiseasePHASE2 · COMPLETED · started Dec 28, 2021ClinicalTrials.gov NCT05233774 · fetched Nov 12, 2026
- Safety, Efficacy and Pharmacokinetics of Rifaximin in Patients With Moderate-to-severe Papulopustular RosaceaPHASE2 · COMPLETED · started Oct 5, 2021ClinicalTrials.gov NCT05150587 · fetched Nov 12, 2026
- A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19PHASE2 · UNKNOWN · started Mar 20, 2021ClinicalTrials.gov NCT04780685 · fetched Nov 12, 2026
- B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic DermatitisPHASE2 · COMPLETED · started Jun 24, 2020ClinicalTrials.gov NCT04490109 · fetched Nov 12, 2026
- A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)PHASE2 · COMPLETED · started Feb 19, 2019ClinicalTrials.gov NCT03832946 · fetched Nov 12, 2026
- A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate RosaceaPHASE2 · COMPLETED · started Jul 2, 2018ClinicalTrials.gov NCT03590366 · fetched Nov 12, 2026
- Comparison Between Podofilox Topical Gel 0.5% and Allergan's Condylox® Gel 0.5% for External Anogenital WartsPHASE3 · COMPLETED · started Apr 20, 2018ClinicalTrials.gov NCT03532776 · fetched Nov 12, 2026
- A Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimite™ in Subjects With ScabiesPHASE3 · COMPLETED · started Apr 10, 2018ClinicalTrials.gov NCT03973775 · fetched Nov 12, 2026
- A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head LicePHASE3 · COMPLETED · started Oct 2, 2017ClinicalTrials.gov NCT03337490 · fetched Nov 12, 2026
- Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies.PHASE3 · COMPLETED · started Nov 1, 2016ClinicalTrials.gov NCT02978508 · fetched Nov 12, 2026
- A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of RosaceaPHASE3 · COMPLETED · started Feb 1, 2015ClinicalTrials.gov NCT02393937 · fetched Nov 12, 2026
- Bio-equivalence Study Between SAPHRIS and AsenapinePHASE1 · COMPLETED · started Jul 1, 2013ClinicalTrials.gov NCT01948024 · fetched Nov 12, 2026